News
Videos
Conferences
Events
Resources
Subscribe

|Articles|October 2, 2017

Take the CURE Magazine Survey

Author(s)Staff

Thank you for answering the questions below.

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Image of Dr. Obeid.

Risk Assessment Remains Vital for Patients Even After Cancer Diagnosis

ByDr. Elias Obeid

January 30th 2026

Bonnie Annis

The Last Walk Down the Hall: Reflections Before Entering Cancer Survivorship

January 30th 2026

Dr. Brittany Dulmage explains how biotin can interfere with lab testing during cancer care: © The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).

Biotin, Lab Interference and Safer Options for Cancer-Related Hair Loss

January 30th 2026

Lung

FDA Accepts Ivonescimab Application for EGFR Lung Cancer

BySpencer Feldman

January 30th 2026

breast cancer

Study Identifies Why Some Breast Cancers Resist Enhertu Treatment

January 30th 2026

Trending on CURE

Most Patients With HER2+ Breast Cancer Miss Standard Treatment, Study Shows

Expert insights into Biomarker-Driven Care and Emerging Targets in GI Cancer

Study Identifies Why Some Breast Cancers Resist Enhertu Treatment

FDA Fast Tracks LBL-034 in Relapsed or Refractory Multiple Myeloma

FDA Accepts Ivonescimab Application for EGFR Lung Cancer